Gene · 7329
Papers3,237
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 3,237
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm. | PLoS One | 2020 | 33006999 | PubTator, text mining | PubMed |
| SUMOylation of PUM2 promotes the vasculogenic mimicry of glioma cells via regulating CEBPD. | Clin Transl Med | 2020 | 32997416 | PubTator, text mining | PubMed |
| Klebsiella pneumoniae Reduces SUMOylation To Limit Host Defense Responses. | mBio | 2020 | 32994335 | PubTator, text mining | PubMed |
| Proteomic analysis of the cellular response to a potent sensitiser unveils the dynamics of haptenation in living cells. | Toxicology | 2020 | 32991956 | PubTator, text mining | PubMed |
| An unanticipated tumor-suppressive role of the SUMO pathway in the intestine unveiled by Ubc9 haploinsufficiency. | Oncogene | 2020 | 32948837 | PubTator, text mining | PubMed |
| Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer. | Cell Commun Signal | 2020 | 32948192 | PubTator, text mining | PubMed |
| Extensive SUMO Modification of Repressive Chromatin Factors Distinguishes Pluripotent from Somatic Cells. | Cell Rep | 2020 | 32937131 | PubTator, text mining | PubMed |
| Lysine acylation using conjugating enzymes for site-specific modification and ubiquitination of recombinant proteins. | Nat Chem | 2020 | 32929246 | PubTator, text mining | PubMed |
| TRIM28 functions as the SUMO E3 ligase for PCNA in prevention of transcription induced DNA breaks. | Proc Natl Acad Sci U S A | 2020 | 32900933 | PubTator, text mining | PubMed |
| Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis. | iScience | 2020 | 32895641 | PubTator, text mining | PubMed |
| The SUMO Conjugase Ubc9 Protects Dopaminergic Cells from Cytotoxicity and Enhances the Stability of α-Synuclein in Parkinson's Disease Models. | eNeuro | 2020 | 32887693 | PubTator, text mining | PubMed |
| The Effect of Dysfunctional Ubiquitin Enzymes in the Pathogenesis of Most Common Diseases. | Int J Mol Sci | 2020 | 32882786 | PubTator, text mining | PubMed |
| Fatty Acid Synthase: An Emerging Target in Cancer. | Molecules | 2020 | 32872164 | PubTator, text mining | PubMed |
| Genome-wide DNA methylation analysis by MethylRad and the transcriptome profiles reveal the potential cancer-related lncRNAs in colon cancer. | Cancer Med | 2020 | 32869528 | PubTator, text mining | PubMed |
| Stability of Begomoviral pathogenicity determinant βC1 is modulated by mutually antagonistic SUMOylation and SIM interactions. | BMC Biol | 2020 | 32867776 | PubTator, text mining | PubMed |
| Constructing cancer patient-specific and group-specific gene networks with multi-omics data. | BMC Med Genomics | 2020 | 32854705 | PubTator, text mining | PubMed |
| Inhibition of Polo-like kinase 1 (PLK1) facilitates the elimination of HIV-1 viral reservoirs in CD4+ T cells ex vivo. | Sci Adv | 2020 | 32832623 | PubTator, text mining | PubMed |
| TIP60 K430 SUMOylation attenuates its interaction with DNA-PKcs in S-phase cells: Facilitating homologous recombination and emerging target for cancer therapy. | Sci Adv | 2020 | 32832608 | PubTator, text mining | PubMed |
| The pathophysiology of neurodegenerative disease: Disturbing the balance between phase separation and irreversible aggregation. | Prog Mol Biol Transl Sci | 2020 | 32828466 | PubTator, text mining | PubMed |
| Molecular signature for senile and complicated cataracts derived from analysis of sumoylation enzymes and their substrates in human cataract lenses. | Aging Cell | 2020 | 32827359 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7329/papers?page=49